AXON
Price
$558.18
Change
+$16.98 (+3.14%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
42.03B
41 days until earnings call
PDSB
Price
$1.15
Change
+$0.07 (+6.48%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
52.62M
42 days until earnings call
Ad is loading...

AXON vs PDSB

Header iconAXON vs PDSB Comparison
Open Charts AXON vs PDSBBanner chart's image
Axon Enterprise
Price$558.18
Change+$16.98 (+3.14%)
Volume$11.75K
Capitalization42.03B
PDS Biotechnology
Price$1.15
Change+$0.07 (+6.48%)
Volume$6.22K
Capitalization52.62M
AXON vs PDSB Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. PDSB commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and PDSB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (AXON: $541.20 vs. PDSB: $1.08)
Brand notoriety: AXON and PDSB are both not notable
AXON represents the Aerospace & Defense, while PDSB is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 57% vs. PDSB: 64%
Market capitalization -- AXON: $42.03B vs. PDSB: $52.62M
AXON [@Aerospace & Defense] is valued at $42.03B. PDSB’s [@Biotechnology] market capitalization is $52.62M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $217.36B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $16.88B. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whilePDSB’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • PDSB’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 5 TA indicator(s) are bullish while PDSB’s TA Score has 4 bullish TA indicator(s).

  • AXON’s TA Score: 5 bullish, 2 bearish.
  • PDSB’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, AXON is a better buy in the short-term than PDSB.

Price Growth

AXON (@Aerospace & Defense) experienced а -6.23% price change this week, while PDSB (@Biotechnology) price change was -18.18% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -2.62%. For the same industry, the average monthly price growth was +0.36%, and the average quarterly price growth was +16.06%.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.95%. For the same industry, the average monthly price growth was -7.12%, and the average quarterly price growth was -11.69%.

Reported Earning Dates

AXON is expected to report earnings on May 13, 2025.

PDSB is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Aerospace & Defense (-2.62% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-4.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($42B) has a higher market cap than PDSB($52.6M). AXON YTD gains are higher at: -8.938 vs. PDSB (-33.742). AXON has higher annual earnings (EBITDA): 437M vs. PDSB (-36.65M). AXON has more cash in the bank: 986M vs. PDSB (49.8M). PDSB has less debt than AXON: PDSB (24.7M) vs AXON (722M). AXON has higher revenues than PDSB: AXON (2.08B) vs PDSB (0).
AXONPDSBAXON / PDSB
Capitalization42B52.6M79,848%
EBITDA437M-36.65M-1,192%
Gain YTD-8.938-33.74226%
P/E Ratio109.57N/A-
Revenue2.08B0-
Total Cash986M49.8M1,980%
Total Debt722M24.7M2,923%
FUNDAMENTALS RATINGS
AXON vs PDSB: Fundamental Ratings
AXON
PDSB
OUTLOOK RATING
1..100
832
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
12100
SMR RATING
1..100
4799
PRICE GROWTH RATING
1..100
4292
P/E GROWTH RATING
1..100
69100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDSB's Valuation (41) in the Pharmaceuticals Major industry is somewhat better than the same rating for AXON (92) in the Biotechnology industry. This means that PDSB’s stock grew somewhat faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (12) in the Biotechnology industry is significantly better than the same rating for PDSB (100) in the Pharmaceuticals Major industry. This means that AXON’s stock grew significantly faster than PDSB’s over the last 12 months.

AXON's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for PDSB (99) in the Pharmaceuticals Major industry. This means that AXON’s stock grew somewhat faster than PDSB’s over the last 12 months.

AXON's Price Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for PDSB (92) in the Pharmaceuticals Major industry. This means that AXON’s stock grew somewhat faster than PDSB’s over the last 12 months.

AXON's P/E Growth Rating (69) in the Biotechnology industry is in the same range as PDSB (100) in the Pharmaceuticals Major industry. This means that AXON’s stock grew similarly to PDSB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONPDSB
RSI
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEHR7.850.56
+7.68%
Aehr Test Systems
SHOP97.642.16
+2.26%
Shopify Inc
KBR49.930.12
+0.24%
KBR
AMWD58.44-0.39
-0.66%
American Woodmark Corp
RMTI1.08-0.05
-4.42%
Rockwell Medical

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-9.24%
AXON - PDSB
43%
Loosely correlated
+2.90%
RXRX - PDSB
43%
Loosely correlated
-3.69%
KYMR - PDSB
41%
Loosely correlated
-7.80%
ATOS - PDSB
37%
Loosely correlated
-3.25%
ATXS - PDSB
36%
Loosely correlated
+1.12%
More